CN(C1CC(C)(C)N(O)C(C)(C)C1)S(=O)(=O)CC12CCC(CC1=O)C2(C)C.Cl
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?